Emerging therapies for malignant pleural mesothelioma

Abstract Malignant pleural mesothelioma continues to challenge clinicians and scientists, since its incidence is rising and prognosis is far from favorable. Currently, the standard treatment consists of a combination of cisplatin and pemetrexed. The role of surgery and multimodality treatment remain...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Quispel-Janssen, Josine M. M. F. [verfasserIn]

Baas, Paul [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2012

Schlagwörter:

Antineoplastic combined chemotherapy protocols/therapeutic use

Combined modality therapy

Drug resistance, neoplasm

Humans

Mesothelioma/drug therapy/pathology/surgery

Neoplasm staging

Pleural neoplasms/drug therapy/pathology/surgery

Extrapleural pneumonectomy

Übergeordnetes Werk:

Enthalten in: Current respiratory care reports - New York, NY : Springer, 2012, 1(2012), 2 vom: 08. März, Seite 91-100

Übergeordnetes Werk:

volume:1 ; year:2012 ; number:2 ; day:08 ; month:03 ; pages:91-100

Links:

Volltext

DOI / URN:

10.1007/s13665-012-0010-4

Katalog-ID:

SPR032139128

Nicht das Richtige dabei?

Schreiben Sie uns!